GMI現況

GMI小孢子靈芝免疫調節蛋白質結合多種創新技術,
己取得結構,檢驗與多種應用專利,同時持續累積發表學術文獻並取得多項國際認證。

GMI Certification
A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells 2021-11-07

Abstract

Dysregulation of human epidermal growth factor receptor pathways by over-expression or constitutive activation can promote lung tumor processing including angiogenesis and metastasis and is associated with poor prognosis in non-small cell lung cancers. Ganoderma also known as Lingzhi has been one of the most popular chemoprevention mushrooms in East Asia for centuries. Among many bioactive components identified from Ganoderma, an immunomodulatory protein is the major ingredient for the treatment of lung cancer.

 

出處聯結:https://doi.org/10.1016/j.procbio.2010.06.006

參考資料:  台灣:靈芝蛋白GMI 可遏止EGF對肺腺癌細胞的煽動,降低癌轉移的可能

聯絡我們
聯絡位置

222 新北市深坑區北深路三段270巷12號8樓之1

聯絡電話

+886-2-2662-0148